Menu
The 7th DIA China Annual Meeting
Session 1006 Generic Drug Forum - II - Product Development for Quality Consistency
Session Chair(s)
Yi REN, PhD, MBA
- General Manager
- Nanjing Medichem Bio-Pharmaceutical Development Co. , China
Jane Y. Cai, PhD
- Former Managing Director
- DIA China, China
Generic reevaluation DIA meeting (EN&CN)
Speaker(s)
Generic reevaluation DIA meeting (EN&CN)
Xinsheng Sun
- Director
- China Quality Association for Pharmaceuticals(CQAP), China
1006-2_BingLi_Scientific and Regulatory Considerations for Establishing Bioequivalence of Generic Drug Products in USA (EN&CN).pdf
Bing V. Li
- Pharmacologist
- FDA, United States
Considerations for OTC Development For Emerging Markets (EN&CN)
Chao Ye, PhD
- Associate Director, Research and Development, OTC
- Johnson & Johnson China, China
Contact us
For exhibition, advertising and hosting inquiry, please contact:
Jean XU: jxu@kellencompany.com, or Sofie Peeters: speeters@kellencompany.com
Tel: +86 10 5923 1096
For general inquiry, please contact DIA China office:
dia@diachina.org
Tel: +86 10 5704 2650